Daiwa Securities Downgrades Bristol-Myers Squibb Co (BMY) to a Neutral from an Outperform

Jaxson Clark

Bristol-Myers Squibb Co’s recent filing unveils that its EVP, Chief Financial Officer Elkins David V unloaded Company’s shares for reported $2.65 million on Sep 02 ’25. In the deal valued at $47.33 per share,56,000 shares were sold. As a result of this transaction, Elkins David V now holds 167,379 shares worth roughly $7.63 million.

Then, Elkins David V bought 56,000 shares, generating $2,648,800 in total proceeds.

Before that, Short Bartie Wendy sold 378 shares. Bristol-Myers Squibb Co shares valued at $16,719 were divested by the EVP, Corporate Affairs at a price of $44.23 per share. As a result of the transaction, Short Bartie Wendy now holds 5,066 shares, worth roughly $0.23 million.

Daiwa Securities downgraded its Bristol-Myers Squibb Co [BMY] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Cantor Fitzgerald began covering BMY with “Neutral” recommendation on April 22, 2025. Jefferies revised its rating on December 16, 2024. It rated BMY as “a Buy” which previously was an “a Hold”.

Price Performance Review of BMY

On Tuesday, Bristol-Myers Squibb Co [NYSE:BMY] saw its stock fall -0.93% to $45.59. Over the last five days, the stock has gained 6.47%. Bristol-Myers Squibb Co shares have fallen nearly -18.25% since the year began. Nevertheless, the stocks have fallen -19.40% over the past one year. While a 52-week high of $63.33 was reached on 03/11/25, a 52-week low of $42.52 was recorded on 10/29/25.

Levels Of Support And Resistance For BMY Stock

The 24-hour chart illustrates a support level at 45.12, which if violated will result in even more drops to 44.64. On the upside, there is a resistance level at 46.33. A further resistance level may holdings at 47.07.

How much short interest is there in Bristol-Myers Squibb Co?

A steep rise in short interest was recorded in Bristol-Myers Squibb Co stocks on 2025-10-15, growing by 0.89 million shares to a total of 30.36 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 29.47 million shares. There was a rise of 2.92%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.